| Product Name | MF | CAS | Details |
|---|
| Etamicastat | C14H15F2N3OS | 760173-05-5 | Details |
| GSK1521498 free base (hydrochloride) | C24H21ClF2N4 | 1007578-24-6 | Details |
| GSK2973980A | C25H19F5N4O4 | 2219321-25-0 | Details |
| Kv3 modulator 2 | C21H21N3O4 | 2101321-76-8 | Details |
| FXIa-IN-1 | C20H19F3N4O5 | 1803271-50-2 | Details |
| IQB-782 | C4H9N3O2S | 40454-21-5 | Details |
| EML741 | C31H49N5O2 | 2328074-38-8 | Details |
| Lp-PLA2-IN-2 | C19H23FN2O4S | 2071636-15-0 | Details |
| MBM-17S | C32H34N6O6 | 2083621-91-2 | Details |
| SRT3657 | C40H54N8O6S | 1383551-17-4 | Details |
| IRAK4-IN-6 | C25H32N10O2 | 2454244-02-9 | Details |
| FadD32 Inhibitor-1 | C24H20ClN3O | 2081969-24-4 | Details |
| (R)-MIK665 | C47H44ClFN6O6S | 1799831-02-9 | Details |
| Kv3 modulator 3 | C19H18N4O3 | 1498186-01-8 | Details |
| MK-7145 | C26H30N2O6 | 1255204-84-2 | Details |
| MARK-IN-1 | C22H23F2N7OS | 1109283-93-3 | Details |
| Ebopiprant | C30H34FN3O5S2 | 2005486-31-5 | Details |
| RAF mutant-IN-1 | C23H17Cl2FN6O2S | 2340020-82-6 | Details |
| Telomerase-IN-3 | C19H16ClN5O3 | 150096-77-8 | Details |
| KDM4-IN-2 | C25H26N6O | 2369607-62-3 | Details |
| PD-1-IN-22 | C25H25N5O4 | 2349372-98-9 | Details |
| S-8510 phosphate | C12H13N4O6P | 151466-23-8 | Details |
| Prolyl Hydroxylase inhibitor 1 | C19H18ClN5O4 | 2205125-60-4 | Details |
| hDDAH-1-IN-2 | C8H20N4O2 | 2408834-77-3 | Details |
| Kgp-IN-1 | C19H24F4N4O3 | 2097865-36-4 | Details |
| ML218 hydrochloride | C19H27Cl3N2O | 2319922-08-0 | Details |
| ROR agonist-1 | C21H20F6N2O5S | 2361528-74-5 | Details |
| IV-23 | C18H18BrNO4 | 2326007-49-0 | Details |
| RIP2 Kinase Inhibitor 3 | C19H24N4O3S | 1398053-50-3 | Details |
| PERK-IN-3 | C22H16F2N4O2 | 1337532-08-7 | Details |
| LpxH-IN-AZ1 | C21H22F3N3O3S | 901260-40-0 | Details |
| TAB29 | C28H22O3 | 2361144-71-8 | Details |
| SMYD2-IN-1 | C25H25Cl2F2N7O2 | 2023788-96-5 | Details |
| OT antagonist 3 | C21H20N6O2 | 925703-75-9 | Details |
| Kv3 modulator 1 | C20H20N4O4 | 1380696-64-9 | Details |
| QPX7728 methoxy acetoxy methy ester | C14H14BFO7 | 2170834-57-6 | Details |
| ELN318463 | C19H20BrClN2O3S | 851600-86-7 | Details |
| ERK2 IN-1 | C36H34FN7O2S | 1093061-47-2 | Details |
| IDO/TDO-IN-1 | C25H24FN5 | 2033173-01-0 | Details |
| GLPG1205 | C22H22N2O4 | 1445847-37-9 | Details |
| FGFR4-IN-4 | C28H32Cl2N6O5 | 2230973-67-6 | Details |
| KRAS inhibitor-4 | C30H39ClN8O | 2374152-69-7 | Details |
| Menin-MLL inhibitor 4 | C32H38FN7O3 | 2169916-13-4 | Details |
| TGFBR1-IN-1 | C23H17N5O2S | 2170830-26-7 | Details |
| LY88074 Trimethyl ether | C24H20O4S | 63675-87-6 | Details |
| RP-001 hydrochloride | C24H25ClN4O4 | 1781880-34-9 | Details |
| HS79 | C19H22N4S | 2138838-56-7 | Details |
| HL271 | C13H17ClF3N5O | 1422365-52-3 | Details |
| IDO1 and HDAC1 Inhibitor | C25H22BrFN8O4 | 2227044-16-6 | Details |
| RAS GTPase inhibitor 1 | C27H28ClF4N5O2 | 2252242-32-1 | Details |
| SHMT-IN-1 | C18H16Cl2N4O | 1508286-18-7 | Details |
| Norverapamil-d7 | C26H29D7N2O4 | 263175-44-6 | Details |
| TAK-828F | C28H32FN3O5 | 1854901-94-2 | Details |
| P-gp modulator 1 | C41H72N2O6 | 2249749-39-9 | Details |
| Seltorexant hydrochloride | C21H23ClFN7O | 1293284-49-7 | Details |
| MAGL-IN-1 | C22H24FNO3 | 2324160-91-8 | Details |
| MTH1-IN-2 | C24H27N3O5S | 901044-91-5 | Details |
| PF-06726304 acetate | C24H25Cl2N3O5 | 2080306-28-9 | Details |
| QPX7728-OH disodium | C10H6BFNaO5- | 2170848-99-2 | Details |
| GNE684 | C23 H24 N6 O3 | 2438637-64-8 | Details |
| OTS186935 trihydrochloride | C25H27Cl2N5O2 | 2093401-85-3 | Details |
| RORγt Inverse agonist 3 | C29H31Cl2N5O4S | 2364429-77-4 | Details |
| TP-008 | C20H15ClFN5O2 | 1976038-41-1 | Details |
| GNE-616 | C24H23F4N5O3S | 2349371-81-7 | Details |
| NUCC-390 | C23H33N5O | 1060524-97-1 | Details |
| PI3K-IN-9 | C19H23N7O | 2360875-63-2 | Details |
| Sitravatinib malate | C37H35F2N5O9S | 2244864-88-6 | Details |
| TDP1 Inhibitor-1 | C26H26N2O5 | 2248702-80-7 | Details |
| 6751-0002 | C17H12ClNO3 | 51505-10-3 | Details |
| (Rac)-AMG8379 | C25H16ClF2N3O5S | 1641574-26-6 | Details |
| OMDM-6 | C28H42N2O3 | 616884-67-4 | Details |
| (Rac)-BL-918 | C23H15F8N3OS | 2435589-07-2 | Details |
| PHT-7.3 | C24H23N3O3S | 1614225-93-2 | Details |
| GPR35 agonist 1 | C10H4BrN5O5 | 2079880-92-3 | Details |
| HAT-IN-1 | C23H18BrF4N3O4 | 1889281-94-0 | Details |
| NSC 601980 | C15H12N4 | 2070018-27-6 | Details |
| Mcl1-IN-4 | C28H26N2O5S | 1580484-04-3 | Details |
| FM26 | C22H15ClF3N3O3 | 2407981-35-3 | Details |
| Lp-PLA2-IN-3 | C20H13ClF3N3O3S | 2196245-16-4 | Details |
| OT antagonist 1 | C22H22N4O3 | 479080-38-1 | Details |
| Pparδ agonist 1 | C26H27NO5 | 1902161-12-9 | Details |
| RIPK1-IN-3 | C22H19F3N6O3 | 2242677-36-5 | Details |
| GSK 690 Hydrochloride | C24H23N3O.ClH | 2436760-79-9 | Details |
| MCB-3681 | C31H32F2N4O8 | 790704-42-6 | Details |
| Dacarbazine citrate | C12H18N6O8 | 64038-56-8 | Details |
| Epelsiban | C30H38N4O4 | 872599-83-2 | Details |
| Synucleozid hydrochloride | C22H21ClN6 | 2741856-68-6 | Details |
| hDDAH-1-IN-1 | C8H20N4O | 1229238-69-0 | Details |
| MARK-IN-2 | C18H18ClF2N5OS | 1314893-26-9 | Details |
| TD-0212 TFA | C30H35F4N3O6S | 1073549-11-7 | Details |
| SSTR5 antagonist 1 | C28H34FN3O5 | 1628741-91-2 | Details |
| Blonanserin HCl | C23H31ClFN3 | 132812-45-4 | Details |
| Dacarbazine hydrochloride | C6H11ClN6O | 17925-90-5 | Details |
| Syncytial Virus Inhibitor-1 | C23H26N4O3S | 1422496-79-4 | Details |
| Glucokinase activator 1 | C27H20F2N2O7S2 | 1328987-85-4 | Details |
| Ribocil-C Racemate | C21H21N7OS | 2309762-18-1 | Details |
| FAAH-IN-1 | C20H19ClN4OS | 1242441-47-9 | Details |
| S1PR1 modulator 1 | C23H24N2O3S | 2328109-05-1 | Details |
| NPD-1335 | C28H29N3O3 | 2376326-31-5 | Details |
| HS80 | C19H22N4S | 2138838-57-8 | Details |
| Product Total： Product Page： | ||||
| 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 | ||||